SPIA
ATRS

Steward Partners Investment Advisory’s Antares Pharma, Inc. ATRS Stock Holding History

Steward Partners Investment Advisory’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,000
Closed -$16K – 3469
2022
Q1 		$16K Sell
4,000
-77
-2% -$279 ﹤0.01% 2479
2021
Q4 		$15K Sell
4,077
-475
-10% -$1.66K ﹤0.01% 2460
2021
Q3 		$17K Buy
4,552
+552
+14% +$2.23K ﹤0.01% 2405
2021
Q2 		$17K Sell
4,000
-5,900
-60% -$24K ﹤0.01% 5320
2021
Q1 		$40.7K Buy
9,900
+5,900
+148% +$25.6K ﹤0.01% 2087
2020
Q4 		$16K Sell
4,000
-1,200
-23% -$3.88K ﹤0.01% 2146
2020
Q3 		$14K Buy
5,200
+2,842
+121% +$7.87K ﹤0.01% 2028
2020
Q2 		$6K Buy
2,358
+1,000
+74% +$2.79K ﹤0.01% 2245
2020
Q1 		$3K Buy
1,358
+558
+70% +$1.9K ﹤0.01% 2250
2019
Q4 		$3K Buy
800
+250
+45% +$1.02K ﹤0.01% 2396
2019
Q3 		$1K Buy
+550
New +$1.81K ﹤0.01% 2579

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Steward Partners Investment Advisory's ATRS Position: Q2 2022 in Review

Steward Partners Investment Advisory sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 4,000 shares — an estimated $16K sold.

Steward Partners Investment Advisory first reported a position in ATRS in Q3 2019 and held it in 11 quarters. The position peaked at $40.7K in Q1 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Steward Partners Investment Advisory reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 4,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $16K.
  • Steward Partners Investment Advisory first reported a position in Antares Pharma, Inc. in Q3 2019 and held it in 11 quarters.
  • Steward Partners Investment Advisory's Antares Pharma, Inc. position peaked at $40.7K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2022, filed 4 Aug 2022.